Aagami, Inc., is a life sciences consulting firm offering,
· Technology Licensing
· Strategic Consulting
· Market Intelligence
For Global companies in
· Technology Licensing Office of Universities
· Medical Devices & Technology
· Pharma
· Biotech
· Consumer Healthcare
· CROs, CDMOs
In Brief, Aagami Brings:
· Deep Experience of overcoming business and socio-cultural differences of various countries
· Extensive ‘C’ level network nurtured for over 15 years
· Global Deal making skills, honed for decades
· Partners having combined experience of 250+ years
· Supplementing your bandwidth to save time, effort & cost
75+ Bio Pharma clients globally across 125+ assignments have put their trust in Aagami since 2003.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. In / Out Licensing
3. Partnership / Co- development
4. Divestiture/ Mergers / Acquisition
5. IP Licensing and Sale
6. Funding and Investment Advisory
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions
2. Extensive ‘C’ level network nurtured for over 18 years
3. Global Deal making skills, honed for decades
4. Partners having combined experience of 250+ years
5. Supplementing your bandwidth to save time, effort & cost
95+ Bio Pharma clients globally have put their trust in Aagami (150+ assignments) since 2003.
It was my OB presentation on Thermo Fisher scientific ltd. We have covered journey of Thermo Fisher, Organisation structure, Organisation configuration, Organisation Design, Integrated Model, Relationship with Organizations, Culture etc topics.
Health Tech Strategy Extern job descriptionKeith Rabkin
Hey everyone, my team is looking to hire two externships out of consulting. If you're at any of the firms that offer an externship or know someone who is, this is a great chance to work with a team tackling some interesting challenges at the intersection of Tech and Healthcare. Please let me know if you have any questions.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. In / Out Licensing
3. Partnership / Co- development
4. Divestiture/ Mergers / Acquisition
5. IP Licensing and Sale
6. Funding and Investment Advisory
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions
2. Extensive ‘C’ level network nurtured for over 18 years
3. Global Deal making skills, honed for decades
4. Partners having combined experience of 250+ years
5. Supplementing your bandwidth to save time, effort & cost
95+ Bio Pharma clients globally have put their trust in Aagami (150+ assignments) since 2003.
It was my OB presentation on Thermo Fisher scientific ltd. We have covered journey of Thermo Fisher, Organisation structure, Organisation configuration, Organisation Design, Integrated Model, Relationship with Organizations, Culture etc topics.
Health Tech Strategy Extern job descriptionKeith Rabkin
Hey everyone, my team is looking to hire two externships out of consulting. If you're at any of the firms that offer an externship or know someone who is, this is a great chance to work with a team tackling some interesting challenges at the intersection of Tech and Healthcare. Please let me know if you have any questions.
We're a specialist global team, which means you get access to the best Life Sciences candidates in the world. You can rely on us to deliver across all of your locations.
In the Guide you will find information about organisations offering
accounting positions to students and who are accredited to train and
employ Chartered Accountants.
Aagami Corporate Presentation April 2022Aagami, Inc.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. In / Out Licensing
3. Partnership / Co- development
4. Funding and Investment Advisory
5. Divestiture/ Mergers / Acquisition
6. IP Licensing and Sale
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions
2. Extensive ‘C’ level network nurtured for over 19 years
3. Global Deal making skills, honed for decades
4. Partners having combined experience of 250+ years
5. Supplementing your bandwidth to save time, effort & cost
100+ Bio Pharma clients globally have put their trust in Aagami (150+ assignments) since 2003.
We are driven by a passionfor transforming products into brands and patients into survivors. Navicor is a 100% healthcare-focused, full-service agency that understands the unique aspects of the oncology marketplace. We have extensive oncology launch experience and have partnerships with large and small pharma and biotech companies.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
- Strategic Consulting
- Out/In Licensing support
- Partnership / Co- development support
- Funding and Investment Advisory
- Divestiture/ M&A
- IP Licensing and Sale
- Market Entry / Development Strategy
In brief, Aagami brings:
- Deep Experience of overcoming business and socio-cultural differences of various countries/regions. Our partners have lived and worked in regions such as Japan, Spain, Germany, India, Colombia, apart from the US
- Extensive ‘C’ level network nurtured for over 20 years
- Global Deal making skills, honed for decades
- Partners having combined experience of 250+ years
- Supplementing bandwidth to save time, effort & cost
108+ Bio Pharma clients globally have put their trust in Aagami (175+ assignments) since last 20 years.
We're a specialist global team, which means you get access to the best Life Sciences candidates in the world. You can rely on us to deliver across all of your locations.
In the Guide you will find information about organisations offering
accounting positions to students and who are accredited to train and
employ Chartered Accountants.
Aagami Corporate Presentation April 2022Aagami, Inc.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. In / Out Licensing
3. Partnership / Co- development
4. Funding and Investment Advisory
5. Divestiture/ Mergers / Acquisition
6. IP Licensing and Sale
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions
2. Extensive ‘C’ level network nurtured for over 19 years
3. Global Deal making skills, honed for decades
4. Partners having combined experience of 250+ years
5. Supplementing your bandwidth to save time, effort & cost
100+ Bio Pharma clients globally have put their trust in Aagami (150+ assignments) since 2003.
We are driven by a passionfor transforming products into brands and patients into survivors. Navicor is a 100% healthcare-focused, full-service agency that understands the unique aspects of the oncology marketplace. We have extensive oncology launch experience and have partnerships with large and small pharma and biotech companies.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
- Strategic Consulting
- Out/In Licensing support
- Partnership / Co- development support
- Funding and Investment Advisory
- Divestiture/ M&A
- IP Licensing and Sale
- Market Entry / Development Strategy
In brief, Aagami brings:
- Deep Experience of overcoming business and socio-cultural differences of various countries/regions. Our partners have lived and worked in regions such as Japan, Spain, Germany, India, Colombia, apart from the US
- Extensive ‘C’ level network nurtured for over 20 years
- Global Deal making skills, honed for decades
- Partners having combined experience of 250+ years
- Supplementing bandwidth to save time, effort & cost
108+ Bio Pharma clients globally have put their trust in Aagami (175+ assignments) since last 20 years.
Medtech.Capabilities.Frost & Sullivan.2009Siddharth Singh
Frost & Sullivan is a growth consulting company. The "Healthcare Practices" focuses on identifying emerging opportunities in Medical Devices industry and offer various market strategies.
Aagami Corporate Presentation March 2024Aagami, Inc.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
1. Strategic Consulting
2. Out/In Licensing support
3. Partnership / Co- development support
4. Funding and Investment Advisory
5. Divestiture/ M&A
6. IP Licensing and Sale
7. Market Entry / Development Strategy
In brief, Aagami brings:
1. Deep Experience of overcoming business and socio-cultural differences of various countries/regions. Our partners have lived and worked in regions such as Japan, Spain, Germany, India, Colombia, apart from the US.
2. Extensive ‘C’ level network nurtured for over 21 years.
3. Global Deal making skills, honed for decades.
4. Partners having combined experience of 250+ years.
5. Supplementing bandwidth to save time, effort & cost.
110+ Bio Pharma clients globally have put their trust in Aagami (180+ assignments) since last 21 years.
Practice Areas: New Product Planning, Business Development and Licensing, Commercial Strategy and Analytics, and Epidemiology and Forecasting.
Our boutique expertise is focused on elucidating patient benefits of bio-pharmaceutical products, medical devices, and businesses. With insightful strategies and solutions aimed at planning and growing our clients’ business, our mission is to continue being the “go-to” firm and preferred partner for our clients in their commercial planning and R&D initiatives.
Our chief operating principle is an unsurpassable commitment to quality and our philosophy has been to develop and sustain strong long-term relationships with clients based on an in-depth understanding of client needs, rigorous research, sound methodologies, and keeping ahead of industry developments.
Aagami Inc. Corporate Presentation JPM 2024Aagami, Inc.
Aagami, Inc., is an Illinois based life sciences consulting firm offering,
Strategic Consulting
Out/In Licensing support
Partnership / Co- development support
Funding and Investment Advisory
Divestiture/ M&A
IP Licensing and Sale
Market Entry / Development Strategy
In brief, Aagami brings:
Deep Experience of overcoming business and socio-cultural differences of various countries/regions. Our partners have lived and worked in regions such as Japan, Spain, Germany, India, Colombia, apart from the US
Extensive ‘C’ level network nurtured for over 21 years
Global Deal making skills, honed for decades
Partners having combined experience of 250+ years
Supplementing bandwidth to save time, effort & cost
110+ Bio Pharma clients globally have put their trust in Aagami (180+ assignments) since last 21+ years.
Hot to Get Telesales Right | AgentCubedJeff Morgan
As an insurance agency, how well are you managing your CRM and lead nurture assets? Are you implementing marketing and sales strategies for maximum conversion? What are the pros and cons of buying versus building your telesales capabilities? How can partnering with a new model help revitalize your telesales experience and drive new business?
Telesales is an increasingly important component for sales growth, distribution diversification, and profitability. The following SlideShare discusses risks, costs, and other considerations associated with telesales strategies. This information will help you select the most viable telesales distribution channel for your business.
This presentation was given at the 9th National Medicare Supplement Insurance Industry Summit by the following subject matter experts:
- John Sowell, Vice President of Medicare Strategic Distribution at Aetna, Inc.
- Ali Hall, Vice President of Sales at AgentCubed
- Christopher Mele, Contact Center Solutions Leader at Aon Hewitt Retiree Solutions
- Ben Henderson, President at Clearlink
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Yavuz Silay
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Aagami Market Intelligence PresentationAagami, Inc.
Aagami, Inc., is a life sciences consulting firm offering,
· Market Intelligence
· Strategic Consulting
· Technology Licensing
For Global companies in
· Pharma
· Biotech
· Consumer Healthcare
· Technology Licensing Office of Universities
· Medical Devices & Technology
· CROs, CDMOs
In Brief, Aagami Brings:
· Deep Experience of overcoming business and socio-cultural differences of various countries
· Supplementing your bandwidth to save time, effort & cost
· Global Deal experience, honed for decades
· Partners having combined experience of 250+ years
· Extensive ‘C’ level network nurtured for over 15 years
75+ Bio Pharma clients globally across 125+ assignments have put their trust in Aagami since 2003.
Presentation made by Aagami at Lifesciences Summit at CGI - 18 MayAagami, Inc.
The Consulate General India - Chicago organized a Life Science Summit on May 18, 2015 at Chicago
Mr. Dinesh Jain, Founder CEO, Aagami Inc. and Mr. Michael Rosen, Managing Director, Rosen Bioscience Strategies (also partner consultant at Aagami) attended the event as speakers and made a presentation on “Life Science Connections between the Midwest and India” as well as some of the life science M&A and FDI activity going on between the U.S. and India”
Consulate General of India - Chicago - Lifescience summit AgendaAagami, Inc.
“Life Science Summit” on May 18, 2015 between 11:30am (Registration + Networking + Lunch) to 3:30pm.
Also attached is the agenda for the event.
Venue - 455 North Cityfront Plaza Drive, 8, NBC Tower, Chicago, IL 60611
Mr. Dinesh Jain, Founder CEO, Aagami Inc. and
Mr. Michael Rosen, Managing Director, Rosen Bioscience Strategies
will be attending as speakers and will make a presentation on
“Life Science Connections between the Midwest and India” as well as some of the life science M&A and FDI activity going on between the U.S. and India”
Study of Market Potential and Prospective Partners in India for hand-held qPC...Aagami, Inc.
Client:
Innovation Center of a New Zealand University focused on Health Sciences
Client Need:
A mobile, lightweight molecular diagnostic technology and device was developed at the University. Its Innovation center wanted to study the market potential in India.
As per Aagami’s suggestion, client agreed to include regulatory overview and potential partners in the study.
Results:
The report helped the University in determining conclusively on India market initiative.
Pleased with the report, the University appointed Aagami to find a licensing partner in India
Since its inception in February 2003, Aagami has assisted over 4 dozen small and large North/South American, European, Japanese and Australian companies in their initiatives. We have brought success to over 63% of our assignments and failed only 4% of the times.
Amazing Facts and Figures - A compilation by AagamiAagami, Inc.
Summary of Contents
India – an Introduction
India LifeSciences Industry Snapshot
Major Centers of Lifesciences in India – Public & Private
Major International Deals with India by Global Companies
What Indian LifeSciences firms are Looking for
About Aagami and how it supports global companies in their India Initiatives
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Skye Residences | Extended Stay Residences Near Toronto Airportmarketingjdass
Experience unparalleled EXTENDED STAY and comfort at Skye Residences located just minutes from Toronto Airport. Discover sophisticated accommodations tailored for discerning travelers.
Website Link :
https://skyeresidences.com/
https://skyeresidences.com/about-us/
https://skyeresidences.com/gallery/
https://skyeresidences.com/rooms/
https://skyeresidences.com/near-by-attractions/
https://skyeresidences.com/commute/
https://skyeresidences.com/contact/
https://skyeresidences.com/queen-suite-with-sofa-bed/
https://skyeresidences.com/queen-suite-with-sofa-bed-and-balcony/
https://skyeresidences.com/queen-suite-with-sofa-bed-accessible/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-king-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed-accessible/
#Skye Residences Etobicoke, #Skye Residences Near Toronto Airport, #Skye Residences Toronto, #Skye Hotel Toronto, #Skye Hotel Near Toronto Airport, #Hotel Near Toronto Airport, #Near Toronto Airport Accommodation, #Suites Near Toronto Airport, #Etobicoke Suites Near Airport, #Hotel Near Toronto Pearson International Airport, #Toronto Airport Suite Rentals, #Pearson Airport Hotel Suites
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
India Orthopedic Devices Market: Unlocking Growth Secrets, Trends and Develop...Kumar Satyam
According to TechSci Research report, “India Orthopedic Devices Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the India Orthopedic Devices Market stood at USD 1,280.54 Million in 2024 and is anticipated to grow with a CAGR of 7.84% in the forecast period, 2026-2030F. The India Orthopedic Devices Market is being driven by several factors. The most prominent ones include an increase in the elderly population, who are more prone to orthopedic conditions such as osteoporosis and arthritis. Moreover, the rise in sports injuries and road accidents are also contributing to the demand for orthopedic devices. Advances in technology and the introduction of innovative implants and prosthetics have further propelled the market growth. Additionally, government initiatives aimed at improving healthcare infrastructure and the increasing prevalence of lifestyle diseases have led to an upward trend in orthopedic surgeries, thereby fueling the market demand for these devices.
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Taurus Zodiac Sign_ Personality Traits and Sign Dates.pptxmy Pandit
Explore the world of the Taurus zodiac sign. Learn about their stability, determination, and appreciation for beauty. Discover how Taureans' grounded nature and hardworking mindset define their unique personality.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
Improving profitability for small businessBen Wann
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...PaulBryant58
This article provides a comprehensive guide on how to
effectively manage the convert Accpac to QuickBooks , with a particular focus on utilizing online accounting services to streamline the process.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
Aagami Technology Licensing Presentation
1. Technology Licensing
→ Realizing Possibilities, Together ←
2135 City Gate Lane, Suite 300, Naperville, IL 60653 USA | P: +1-630-364-1837 | www.aagami.com
January 2019
2. A life sciences consulting firm offering
For Global companies in
Aagami, Inc.
Strategic Consulting
Technology
Licensing
Market Intelligence
IP office of
Universities
Pharma Biotech
Medical
Devices
Consumer
Healthcare
2
4. Our Understanding of Tech Transfer Offices Needs
Realistic Evaluation of
commercial potential
Reach in the Investors’
world
Access to Global
Commercial Network
Ability to speak
“Investors’ language”
Commercial Perspective
on
Technology
‘Out of box’ thinking
to widen
market applications
Ability to talk multi
cultural, multi
geographical
“Business’ language”
4
5. Aagami brings,
Value
Proposition
Deep Experience
of overcoming
business and
socio-cultural
differences of
various countries
Extensive ‘C’ level
network nurtured
for over 15 years
Global Deal
making skills,
honed for decades
Partners having
combined
experience of
250+ years
Supplementing
your bandwidth to
save time, effort &
cost
USP
5
6. Aagami, Technology Licensing Services
Consolidate
Industry
demand
Consolidate
available
technologies
Evaluate
Technologies
to fit the
demand
Evaluate
Commercial
Potential
Promote selected
technologies
•Generate focused marketing
brochures
•Broadcast to specific
(relevant) companies
•Exchange information with
the interested
•Help and support finalizing
Licensing agreements
6
7. 7
Sample list of Clients whom we have served
USA
OncBioMune with license from
Louisiana State University LA
Loyola Univ. Chicago IL
DesignMedix with license from
Portland State University OR
University of Messina, Italy Spinoff
CREAGRI® CA
Impel NeuroPharma with license
from University of Washington WA
UT Austin Spinoff DisperSol TX
MacuCLEAR, with license from
Texas A&M University Spinoff TX
International
Univ. Of Bergen Spinoff UTR Norway
Toppan KK, with technology from
RIKEN Japan
Opsona, a spin-out from Trinity
College Dublin Ireland
University of Otago, Dunedin
New
Zealand
Pieris AG, with license from
Technische Universität München
Germany
Recife University based Nanosensing Brazil
Monash Univ. based Phosphagenics Australia
Aagami has completed over 125 assignments for more than 75 clients since 2003
8. 8
Strategy
Segment
IN Licensing
OUT
Licensing
M & A
Partnership
Co-Development
Regulatory
Market
Research
& Entry
Supply Chain &
Distribution
BD
Pharmaceuticals
Biotechnology
Delivery Technology
Diagnostics
CRO & CRAMS
Consumer Health Products
Nutraceuticals/
Cosmeceuticals
Medical Device
Labware
Supported all Segments and Strategies
The colored boxes represent our experience in that Sector and assignment completed in Strategic area
9. Our Proven Approach
Setup
• Understand and capture
important details about your
asset/technology
• Prepare ‘Elevator Pitch
(EP)/Teaser’ customized to
specific business culture
• Identify relevant companies and
the right persons from our
database and resources
Prospect
• Broadcast EP/Teaser to identified
Relevant Companies
• Follow-up with phone calls and
emails
• Coordinate CDAs with interested
Companies
• Supply further info through
emails
• Organize conference calls for
clarifications
Finalize
• Organize Road show
• Manage appointments with right
executives
• Coordinate the logistics of the
road show
• Advise on structuring the deal
• Support in negotiations (most
critical)
All these steps require ~80 hours of effort every month per geography
9
10. 10
Engagement Model
• After 6 months you can
choose to continue based on
progress
• This brings skin in the game of
both parties
• One-time success fee
payment option also
available
• We get our profits only
from Success Bonus
• A senior Consultant, mid-level
consultant, Analyst team
deployed
• Work with focus on your
success as that gives us our
success
Monthly Commitment Fee + Success Fee
Dedicated
Teamwork
Success bonus
Small Monthly
‘Commitment’
Fee
~80 hours/month/geography A small % of value received by
you
for at least 6 months
11. 11
Dinesh Jain, MBA – Founder CEO
• A business leader in Science and technology industry since 1984 with global experience in starting and
managing several technology companies. Has held positions of CEO, President, Vice President, Country
Manager. Executed several dozen international deals across 4 continents. He is a regular speaker in
International conferences on Life Sciences Business and is also on board of several consulting and research
companies.
Dr. Mahendra Shah, Ph D – Scientific & Business Advisor
• A veteran Scientific and Business leader in Bio-Pharmaceutical field for several decades. After his PhD from NY,
worked with some of the top-notch companies like Bristol, Squibb, Schering, Lyphomed, Fujisawa, EJ Financials,
First Horizon, NextWave. Mahendra is an active Investor in BioPharmaceutical field and is on the Board of
several Biotech and Pharma companies.
Michael S. Rosen, MBA - Business
• A Senior executive and entrepreneur working globally since 1974. Managed 3 multinational pharma and agro-
science companies working in Europe, Latin America, Japan, Canada, Asia and Israel. CEO experience starting
and growing several biotech and medical device companies in the U.S. and Europe, raising more than $50
million in equity and taking a company public. Economic development expertise creating and expanding vibrant
science parks and life-science ecosystems as public-private partnerships.
Aagami Leadership Team 1 of 3
12. 12
Aagami Leadership Team 2 of 3
Dr. Shridhar Andurkar, Ph D – Scientific
• Chair and Associate Professor of Pharmaceutical sciences at Midwestern University, Chicago College of
Pharmacy, is a Ph D from Auburn University in Medicinal Chemistry, Conducted postdoctoral research at the
University of Houston.
• Dr. Andurkar has published numerous papers and made several presentations in this field. He holds a US patent
in the area of anticonvulsant drugs and is on the advisory boards of several companies.
Dr. Aman Ahuja, M.D., F.P.M., F.R.C.A. – Medical
• A specialist pain medicine physician and consultant at the North Queensland, Australia.
• MD Anaesthesia from India, Fellow of Royal College of Anaesthetists, Ireland, Masters in Pain Medicine from UK,
Fellow of Tess Cramond Multidisciplinary Pain Centre, Australia.
• Dr. Ahuja has focus on clinical practice, research and advancing rational therapies for a diverse range of
conditions.
• His current interests include studying the expanding role of radiofrequency in field of Pain Medicine. Dr. Ahuja
uses a compassionate and multidisciplinary approach in his well-known practice as a Pain Specialist and
Anesthetist.
13. 13
Nancy Chew – Regulatory
• A serial entrepreneur, veteran business leader, biochemist and Pharmacologist by education
• Nancy’s decades of experience encompass nearly every aspect of regulatory affairs including Strategic Planning,
FDA Liaison, Submissions and Compliance.
• Several top honors & award winner and Advisor to numerous Life Sciences companies.
• Nancy's accomplishments and achievements of working since 1979 would take several pages to detail.
Godwyn Francis – Vice President
• Since 2000 Godwyn has been working with companies like Accenture, Prudential, Tata and other firms in
management consulting.
• At Aagami, Godwyn leads business development and Strategic growth efforts. He provides key support and
oversight to research and consulting assignments for global clients.
• He has worked on multiple term sheets each year and contributed to signing deals worth tens of millions of
dollars.
• His work includes regular engagement with top management of life sciences companies globally.
Aagami Leadership Team 3 of 3
14. In Summary – Aagami, Inc.
Multi-
geographic
presence
Large ‘C’
level
network
20+ deals
75+ Clients
125+
Assignments
Client
Success –
most
important
250+yrs
Global
Experience
Shridhar Andurkar
Nancy Chew
Dinesh Jain
Michael Rosen
US$ 500+MM
X-Border deals
and Investments
14
15. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Facilitating investment for development of targeted therapies
and therapeutic vaccines
• Investments and partnering to further develop its
technologies and pipeline.
15
Louisiana State University spinoff, commercializing University laboratory-developed technologies
• Aagami scanned the global market, identified right investors/
partners, and took them to 50 + companies.
• With focused efforts 10+ companies had post CDA level
scientific and clinical discussions.
• Aagami kept facilitating and persevering, 3 companies
moved to term sheet level discussions.
• Finally Aagami found a right partner to facilitate reverse
merger with a OTC Markets listed company.
• This is enabling access to large sums of funds to develop
clinical stage programs.
• Listing on OTC Markets by a reverse merger
• Financial resources to enable development of existing
pipeline and technologies
16. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Exclusive Worldwide Licensing for a Fragrance and Flavors
Technology
• The University developed an improved process to make Safranal
faster, cheaper, and greener.
• After patenting it they were finding it difficult to out license it
even after more than 2 years of trying .
16
Technology Licensing Office of a reputed University from Chicago area
• Aagami deployed a senior consultant to understand and capture
important details about the asset / technology
• Identified relevant companies in India and elsewhere.
• Shortlisted 68 companies and sent them customized ‘Elevator
Pitch’ (EP)
• After several follow ups on phone calls and emails, coordinated
CDAs and conference calls with several interested Companies and
brought 3 companies on term sheet level discussions
• Aagami supported in structuring and negotiating the deal
discussions.
• Finally established the partnership within 6 months from the start
date
• Technology licensing partnerships made with 2
companies in India in 6 months
• Client said: “It takes a lot of time and people to
pull off an agreement like this, ….. we’re very
pleased that we were able to align ourselves
with these two reputable international
companies.”
http://loyolastudentdispatch.com/2010/11/05/loy
ola-flavor-and-fragrance-research-goes-global/
Lifesciences Catalyst
17. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Establishing Partnerships for Development and
Commercialisation of Novel Class of Protein Drugs
• Innovator partners in India to collaborate on a new class of
proteins - Anticalins® to develop various programs in
Oncology and Ophthalmology.
17
Technical University of Munich spinoff Biotech company making safer, differentiated Novel drugs
• Aagami identified right partners, and took them to 7
interested companies for Anticalins®
• With focused efforts 3 companies moved to term sheet level
discussions. Aagami kept facilitating and persevering. 2
companies remained for final negotiations.
• Aagami maintained its spirits and perseverance knowing
Indian ways of working; even when client was ready to give
up as per Western ways.
• Finally co development partnership happened in next few
months with one company in Oncology.
• Second company took more time and couple of visits before
signing co-development deal for ophthalmic therapy.
• Client signed co-development deals with 2 companies in Oct
and Dec 2013 respectively
• Right companies, right advice, structure, perseverance and
commitment were the key success factor. in making it
happen.
• Aagami proved highly influential in negotiations for
finalization of the deals due to deep experience in business
culture nuances of India.
• It brought repeat and referral business to Aagami.
18. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Study of Market Potential and Prospective Partners in India for
hand-held qPCR Diagnostic Device
• Innovation center wanted to study the market potential in India for their innovative
mobile, lightweight molecular diagnostic technology and device.
• On Aagami’s suggestion, client agreed to include regulatory overview and potential
partners in the study.
18
Innovation Center of a New Zealand University focused on Health Sciences
• Aagami involved a team of a senior and a junior researcher to
conduct secondary and primary research to assess and collect
market data.
• Identified Competitors and their product ranges and also did a
brief comparison analysis.
• Prepared a crisp and concise report with data, analysis and
recommendations
• Also prepared a regulatory overview document
• Captured the potential end users of the product as well as
shortlisted potential partners
• Offered consulting support for Partnership Development and India
Market Entry with a clearly defined Partnering Strategy and
roadmap to achieve the goal.
• The report helped the University in determining
conclusively on India market initiative.
• Pleased with the report, the University
appointed Aagami to find a licensing partner in
India
19. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Global NPV of Technology (in USD Million)
(P) Pessimistic Scenario
Discount rate 8.60%
Year 2012 2013 2014 2015 2016 2017 2018
Time 0 1 2 3 4 5 6
Revenue from Sale of NPTP POC devices - - 20.30 23.62 32.06 40.80 24.93
Revenue from Sale of Treated Cuvette - - 450.00 614.87 815.48 1,021.15 657.19
Total Cost of NPTP POC devices - - 4.10 5.66 7.69 9.78 5.98
Total Cost of Treated Cuvettes - - 175.00 387.88 514.43 644.17 414.57
Commercialisation Costs 400.00 - - - - - -
Total Cash Inflow - - 470.30 638.49 847.54 1,061.96 682.11
Total cash Outflow 400.00 - 179.10 393.54 522.12 653.96 420.55
Net Cash Flow -400.00 - 291.20 244.95 325.43 408.00 261.56
Discount Factor 1.00 0.92 0.85 0.78 0.72 0.66 0.61
Discounted Cash Flow -400.00 - 246.91 191.24 233.96 270.09 159.44
NPV 1,524.77
Assessment of Global Net Present Value (NPV) of a revolutionary
Nanotechnology Based Diagnostic Platform
• Client wanted to commercialize ground breaking technology in the
MI Diagnostics field, and wanted to know its commercial potential
so that suitable licensing fees and model could be determined and
also value could be showcased to Licensees
19
US Investors Controlled Innovation lab from Recife University, Brazil
• Aagami involved a team of a senior consultant part time and a
business analyst full time to conduct primary and secondary
research involving domain specialists to capture current market
scenario.
• Performed competitive benchmarking to assess a Relative Cost
Benefit Index used later for determining technology platform
(product) pricing.
• Projected annual demand for next ten years in three different
scenarios - Median, Optimistic and Pessimistic across multiple
disease categories.
• Forecasted Global Average Selling Price (ASP) and Cost associated
with capex and opex
• Validated commercializing options and measured incremental
financial scenario for potential licensees
• Determined the Global Net Present Value (NPV) and created
Financial models
• NPV of the technology and indicative licensing fees, along with
several insights generated, served as conclusive guidance to the
client for deal-making and negotiations.
• The client was delighted which also resulted in repeat assignments
such as Commercialization Support.
20. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Assessment of NPV of a Patented Anti-Malarial Drug which
Overcomes Microbial Resistance
• A Novel Therapeutics discovery company with focus on anti-
malarial had discovered a Hybrid drug using innovative reversal
agent for drug resistance.
20
Portland State University, US based Novel Therapeutics company focused on drug resistant diseases
• Aagami engaged domain specialists for the client need.
• The malaria market was studied and three different annual demand
scenarios -Pessimistic, Median and Optimistic was projected for 10
years since drug introduction in the market.
• Research on current malaria treatment and available drugs was
conducted to build competitive mapping. Along with inputs from
industry experts, dosage, price and market share data across
competitive drug types was used to build COGS and overall cost
estimates. Value based pricing was also estimated with merits of R&D
Tax Credits were incorporated in the model.
• Using previous drug introductions, and the competitiveness of the drug,
the uptake and adoption rate for the new drug was calculated.
• Finally the Global Net Present Value (NPV) of the client Hybrid drug
(including technology) was done to calculate the indicative license fees
under various scenarios.
• Comprehensive spreadsheet based automated tool with sensitivity
analysis to change inputs and build multiple case scenarios.
• NPV of the drug and indicative licensing fees, along with several
insights generated, served as conclusive guidance to the client for
deal-making and negotiations.
• The client was impressed by the quality of the deliverable and
particularly appreciated the sound, research backed assumptions
and projections.
Lifesciences Catalyst
Market Sizing - Global Anti-Malarial Drug
Safety Stock 15.0%
2000 2001 2002 2003 2004
P
Lower
( In millions)
151 153 152 156 158
M
World Level
( In millions)
226 229 231 236 240
O
Upper
( In millions)
304 307 312 319 325
P 151 153 152 156 158
M 226 229 231 236 240
O 304 307 312 319 325
Malaria Cases (Number
of Cases (95%
confidence interval)
Malaria cases adjusted
for Safety stock etc
21. Case
Study
Client
Client Need
Solution Approach
Results
**Data has been sanitized and meant for Illustrative purposes only
Technology Out-licensing of Transdermal Drug Delivery Technology
with 3 Indian Companies | 4 deals
q To Out-License TPM® Technology and Co-Develop in clinic
products using proprietary Delivery technology and market
such products in India and possibly larger region.
21
TPM® Technology and Products Company from Australia
q Aagami scanned numerous companies and got 10 relevant
companies interested.
q Discussion with 8 companies progressed.
q Took client to India 3 times for term sheet level meetings
and deal signing.
q Facilitated entire evaluation and deal structuring process
q Aagami made sure testing and other protocols were
honoured before deal was made.
q During the process Aagami ensured clear understanding
despite socio cultural differences in styles of working.
q 4 Deals with 3 global companies of India; One Global deal,
One 14 geography deal, other regional deals
–The first deal was struck for diclofenac topical gel formulation
containing TPM platform. The Indian partner not only launched
their own product but also out licensed to a major western pharma.
–The second alliance was struck for use in Skin Whitening and under
eye cream.
–Third deal - Aagami was able to facilitate a new business model
with this prospect, who using client technology increased bio
availability as well as stability of a specific antibiotic.
22. Aagami, Inc.
2135 City Gate Lane Suite 300
Naperville, IL 60653, USA
+1-630-364-1837
Business Development
Godwyn Francis, Vice President
godwyn@aagami.com
+1 630-909-3341
www.aagami.com
Connect with us
22